Vapotherm, Inc.: Business Overview, Financials & Competitive Analysis
Vapotherm, Inc. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Established respiratory technology innovator with proven product utility but transitional dynamics due to pending privatization and market performance pressures. While Vapotherm holds strong market position and differentiated technology in respiratory care, the company faces significant headwinds including a delisting from NYSE to OTC markets (Dec 2023), pending going-private transaction at.
What is Vapotherm, Inc.'s industry? Vapotherm, Inc. (vapotherm.com) operates in Medical Device Manufacturing / Respiratory Support Technology. AskCyborg classifies Vapotherm, Inc. under Medical Device Manufacturing / Respiratory Support Technology in its company registry.
Vapotherm is a medical technology company specializing in non-invasive respiratory support systems. The company develops and commercializes high velocity therapy (HVT) products using proprietary Precision Flow systems...
Cyborg Score thesis
Established respiratory technology innovator with proven product utility but transitional dynamics due to pending privatization...
Read the full analyst-debate transcript →Get the Latest Vapotherm, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeVapotherm, Inc. Overview
Pro stress-test →Vapotherm is a medical technology company specializing in non-invasive respiratory support systems. The company develops and commercializes high velocity therapy (HVT) products using proprietary Precision Flow systems for treating patients with respiratory distress, with over 4.4 million patients treated to date.
Strategic Profile
Pro stress-test →Vapotherm is a pioneer in mask-free respiratory support technology, operating as the market leader in high velocity therapy devices. The company generates revenue through direct hospital sales in the US and international distribution, serving a critical niche in respiratory care with proven clinical outcomes and patient comfort advantages over conventional mask-based therapies.
Competitive Landscape
Pro stress-test →Vapotherm competes in the respiratory device market against established medical device manufacturers including Fisher & Paykel Healthcare, ResMed, Drägerwerk, and Becton Dickinson. The company's differentiation rests on proprietary high velocity therapy technology and mask-free delivery, positioning it uniquely in a niche segment of the broader respiratory support market dominated by larger diversified competitors.
Industry Context
Vapotherm, Inc. operates in Medical Device Manufacturing / Respiratory Support Technology.
Key facts
Founded: 1999 · Headquarters: Exeter, NH, US · Employees: 291 · Revenue: $68.67M